404 related articles for article (PubMed ID: 37532073)
1. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
[TBL] [Abstract][Full Text] [Related]
2. Herbal medicines and nonalcoholic fatty liver disease.
Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
[TBL] [Abstract][Full Text] [Related]
3. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
[TBL] [Abstract][Full Text] [Related]
4. A promising therapy for fatty liver disease: PCSK9 inhibitors.
Han L; Wu L; Yin Q; Li L; Zheng X; Du S; Huang X; Bai L; Wang Y; Bian Y
Phytomedicine; 2024 Jun; 128():155505. PubMed ID: 38547616
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
Liu C; Liao JZ; Li PY
World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.
Dong H; Lu FE; Zhao L
Chin J Integr Med; 2012 Feb; 18(2):152-60. PubMed ID: 22311412
[TBL] [Abstract][Full Text] [Related]
7. Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Cao Y; Fang X; Sun M; Zhang Y; Shan M; Lan X; Zhu D; Luo H
Phytother Res; 2023 Sep; 37(9):3867-3897. PubMed ID: 37449926
[TBL] [Abstract][Full Text] [Related]
8. Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
Liu J; Dong B; Yang L; Huang W; Tang S
Medicine (Baltimore); 2021 May; 100(19):e25358. PubMed ID: 34106587
[TBL] [Abstract][Full Text] [Related]
9. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
10. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Shi KQ; Fan YC; Liu WY; Li LF; Chen YP; Zheng MH
Mol Biol Rep; 2012 Oct; 39(10):9715-22. PubMed ID: 22718512
[TBL] [Abstract][Full Text] [Related]
12. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
[TBL] [Abstract][Full Text] [Related]
13. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular Mechanisms.
Ma C; Wang C; Zhang Y; Zhou H; Li Y
Curr Mol Pharmacol; 2022; 15(6):846-861. PubMed ID: 34923950
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
15. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
16. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.
Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X
Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review.
Zhang X; Jiang Z; Jin X; Zhou Q
Medicine (Baltimore); 2024 Feb; 103(5):e37052. PubMed ID: 38306552
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease].
Pan YT; Xu FY; Yu XZ; Shang WB
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1109-1112. PubMed ID: 29027424
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
20. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
